Onto Innovation Inc. · ONTO · FY2026 Q2 · Calendar Q3 2026

Onto Innovation’s record Q2 results lift advanced-packaging outlook

Onto Innovation’s record Q2 and increased advanced-packaging outlook support a constructive near-term operating picture, while exposure to AI-related demand and the durability of margin gains remain important tests.

Why did ONTO rise 14.7% after beating EPS estimates in FY2026 Q2?

Research this report with FN2. Free to start; review your question before sending.

Reported After market closeNYSETechnology $10.55B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $1.93 Consensus $1.69
EPS surprise +14.2% Reported versus consensus
Reported revenue $343.1M Consensus $325.3M
Revenue surprise +5.5% Reported versus consensus
Check the math in the surprise calculator >

Market reaction

event-close to next-session close
Stock move +14.7% Event window
SPY move +0.6% Same window
Abnormal move +14.1% Stock minus SPY
Volume 1.8× Versus trailing sessions
Subsequent drift -13.1% Up to 20 sessions
ONTOSPY benchmark

Ask FN2 about ONTO FY2026 Q2

Choose a question to continue your research

Free to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.

Transcript intelligence

What changed

Compared with the prior quarter’s outlook for more than 50% full-year advanced-packaging growth, management now expects about 80% growth. Q2 revenue reached $343 million, and backlog exceeded $1.1 billion, with a sizable portion of orders extending into 2027.

Guidance delta

Management raised its second-half revenue growth outlook to more than 25% and its full-year advanced-packaging growth outlook to about 80%.

Key takeaways

  • Q2 revenue was $343 million, up 18% sequentially and 35% year over year; gross margin was 57% and operating margin was 30%.
  • Management cited AI-related demand for advanced packaging, including HBM and 2.5D applications, as a growth driver.
  • Backlog exceeded $1.1 billion, with 30–40% of orders extending into 2027.
  • Dragonfly G5, Iris G2, silicon photonics, and panel-level packaging were highlighted as areas of product momentum.

Management priorities

  • Ramp Dragonfly G5 shipments and grow its revenue contribution.
  • Expand panel-level packaging solutions and silicon photonics offerings.
  • Deepen collaboration with Rigaku on X-ray process-control solutions.
  • Use extended factories to support operational flexibility.

Follow ONTO with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
ONTO REVENUE earnings history estimate and actual scatter chart 10 reported fiscal quarters and 4 future estimate-only quarters. Q2 '24 estimate $235M Q2 '24 actual $242M, beat Q3 '24 estimate $259M Q3 '24 actual $252M, miss Q2 '26 estimate $222M Q2 '26 actual $254M, beat Q3 '26 estimate $220M Q3 '26 actual $218M, miss Q4 '26 estimate $267M Q4 '26 actual $267M, miss Q1 '27 estimate $292M Q1 '27 actual $292M, match Q2 '27 estimate $325M Q2 '27 actual $343M, beat Q3 '27 estimate $392M Q3 '27 actual $410M, beat Q4 '27 estimate $442M Q1 '28 estimate $465M Q2 '28 estimate $492M Q3 '28 estimate $518M
Show 2 more >

Analyst Consensus ?

ConsensusBuy14 ratings
Bullish14100.0%
Neutral00.0%
Bearish00.0%

Analyst 52W Price Targets

$170.16Current
$135Low
$333.5Average
$450High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 22, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Freedom Broker Buy BuyMaintainNov 11, 2026
Stifel Buy BuyMaintainNov 10, 2026
RBC Capital Outperform OutperformMaintainNov 10, 2026
Needham Buy BuyMaintainNov 10, 2026
Morgan Stanley Overweight OverweightMaintainNov 10, 2026
Show 9 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $170.16. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Stifel NicolausBrian Chin$305$194.04 +79.2%Nov 10, 2026
NeedhamCharles Shi$285$194.04 +67.5%Nov 10, 2026
B.Riley FinancialAnalyst unavailable$340$226.28 +99.8%Oct 19, 2026
RBC CapitalSrini Pajjuri$400$314.88 +135.1%Oct 2, 2026
Morgan StanleyShane Brett$360$268.01 +111.6%Sep 8, 2026
See 36 more

Track every rating change on ONTO the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Onto Innovation Inc. is a global leader in designing, manufacturing, and supporting cutting-edge process control solutions. The company's diverse portfolio encompasses tools for macro defect inspection, 2D/3D optical metrology, and lithography systems, alongside sophisticated analytical software for process control. These offerings are crucial for optimizing manufacturing processes, enhancing yield, and facilitating device packaging and testing in various industries worldwide.…

Historical context

All ONTO earnings

Technology peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the ONTO recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-11-09T22:07:01.165134+00:00
  2. FN2 earnings calendar · 2026-09-11T01:23:15.000588+00:00
  3. Polygon adjusted daily market bars · 2026-11-12T02:00:47.715698+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-12T02:00:47.713268+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-11-12. For educational purposes only; not investment advice.